Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-3.4%/yr
vs -1.1%/yr prior
5Y CAGR
+1.2%/yr
Recent deceleration
Acceleration
-2.3pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 83.29% | +37.5% |
| 2024 | 60.56% | -2.2% |
| 2023 | 61.90% | -32.9% |
| 2022 | 92.31% | +50.1% |
| 2021 | 61.50% | -21.5% |
| 2020 | 78.29% | +38.3% |
| 2019 | 56.62% | -41.2% |
| 2018 | 96.30% | -3.4% |
| 2017 | 99.65% | +101.3% |
| 2016 | -7443.00% | - |